CompoAtlas

Prostate Supreme

Natural health product licensed in Canada

Licence holder
Designs for Health
NPN or DIN-HM
80078419
Status
Active licence
Licence date
15 June 2017
Revision date
17 June 2025
Form
Capsule
Route of administration
Orale
Application type
Non traditionnelle

If this product were sold in France

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
Acide aminoacétique

Source : Glycine

50 milligrammeNot calculated
Acide L-glutamique

Source : Acide glutamique

50 milligrammeNot calculated
Lycopène

Source : Lycopène

10 milligrammeNot calculated
Serenoa repens

Source : Fruit

Potency : 45 % Fatty acids

225 milligrammeNot calculated
Vitamine D

Source : Cholécalciférol

12.5 microgrammesNot calculated
Vitamine D

Source : Cholécalciférol

500 UI25 µg
Vitamine B6

Source : Chlorhydrate de pyridoxine

5 milligramme10,000 µg
Zinc

Source : Diglycinate de zinc

5 milligramme10,000 µg
Urtica dioica

Source : Racine

Extract : Matériel brut sec

Extraction ratio : 7-12:1

Dry plant equivalent : 875-1500 milligramme

Potency : 0.8 % beta-Sitosterol

125 milligrammeNot calculated
L-Alanine

Source : L-Alanine

50 milligrammeNot calculated
5,7-dihydroxyflavone

Source : Chrysine

50 milligrammeNot calculated
3,3'-diindolylméthane

Source : 3,3'-diindolylméthane

50 milligrammeNot calculated

Non-medicinal ingredients

Dioxyde de silicium, Gélatine, Stéarate de magnésium

PopulationAgeQuantity per servingFrequency
Adultes de sexe masculinNot specified2 Capsule1 Tous les jours

Uses authorised in Canada

Text supplied in English because no French text is available.

Helps support prostate health.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

No French warning text available in the imported data.

Warnings are available in English on the official record.

Source

Official Health Canada record, licence 80078419

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).

Has the product changed? Photograph the packaging.

Enter to analyse, Shift+Enter for a new line